Augmented expression of hepatocytes growth factor activator inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis

Virchows Archiv

Volumn 449, Issue 4, 2006, Pages 462-471

  Sasaki, Motoko ^a   Ikeda, Hiroko ^a   Kataoka, Hiroaki ^b   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Biliary epithelial cells; Hepatocytes growth factor (HGF); HGF activator (HGFA); HGF activator inhibitor type I (HAI 1); Primary biliary cirrhosis

Indexed keywords

ENZYME ACTIVATOR; HEPATOCYTE GROWTH FACTOR ACTIVATOR; HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR TYPE 1; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; GASTROINTESTINAL MUCOSA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAHEPATIC BILE DUCT; LIVER CELL; LIVER DISEASE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE REPAIR; WOUND HEALING;

BILE DUCTS, INTRAHEPATIC; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; EPITHELIAL CELLS; GENE EXPRESSION; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS, BILIARY; MEMBRANE GLYCOPROTEINS; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTO-ONCOGENE PROTEINS C-MET; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERINE ENDOPEPTIDASES; WOUND HEALING;

EID: 33749037451     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-006-0257-7     Document Type: Article

References (33)

1. Auth MK, Joplin RE, Okamoto M, Ishida Y, McMaster P, Neuberger JM, Blaheta RA, Voit T, Strain AJ (2001) Morphogenesis of primary human biliary epithelial cells: induction in high-density culture or by coculture with autologous human hepatocytes. Hepatology 33:519-529
2. Desmet V, Gerber M, Hoofnagle J, Manns M, Scheuer P (1994) Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19(6):1513-1520
3. Fussey S, Guest J, James O, Bassendine M, Yeaman S (1988) Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci USA 85:8654-8658
4. Gershwin ME, Mackay IR, Sturgess A, Coppel RL (1987) Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 138:3525-3531
5. Halaban R, Rubin JS, Funasaka Y, Cobb M, Boulton T, Faletto D, Rosen E, Chan A, Yoko K, White Wet al (1992) Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene 7:2195-2206
6. Itoh H, Kataoka H (2002) Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa. J Gastroenterol 37(Suppl 14):15-21
7. Joplin R, Hishida T, Tsubouchi H, Daikuhara Y, Ayres R, Neuberger JM, Strain AJ (1992) Human intrahepatic biliary epithelial cells proliferate in vitro in response to human hepatocyte growth factor. J Clin Invest 90:1284-1289
8. Kamihira T, Shimoda S, Harada K, Kawano A, Handa M, Baba E, Tsuneyama K, Nakamura M, Ishibashi H, Nakanuma Y, Gershwin ME, Harada M (2003) Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis. Gastroenterology 125:1379-1387
9. Kaplan M (1996) Primary biliary cirrhosis. New Engl J Med 335:1570-1580
10. Kataoka H, Suganuma T, Shimomura T, Itoh H, Kitamura N, Nabeshima K, Koono M (1999) Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues. J Histochem Cytochem 47:673-682
11. Kataoka H, Itoh H, Hamasuna R, Meng JY, Koono M (2001) Pericellular activation of hepatocyte growth factor/scatter factor (HGF/SF) in colorectal carcinomas: roles of HGF activator (HGFA) and HGFA inhibitor type 1 (HAI-1). Hum Cell 14:83-93
12. Katayanagi K, Kono N, Nakanuma Y (1998) Isolation, culture and characterization of biliary epithelial cells from different anatomical levels of the intrahepatic and extrahepatic biliary tree from a mouse. Liver 18:90-98
13. Kita H, Matsumura S, He XS, Ansari AA, Lian ZX, Van de Water J, Coppel RL, Kaplan MM, Gershwin ME (2002) Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 109:1231-1240
14. Nakanuma Y, Ohta G (1979) Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology 76:1326-1332
15. Nakanuma Y, Sasaki M (1989) Expression of blood-group-related antigens in the intrahepatic biliary tree and hepatocytes in normal livers and various hepatobiliary diseases. Hepatology 10:174-178
16. Neuman M, Angulo P, Malkiewicz I, Jorgensen R, Shear N, Dickson ER, Haber J, Katz G, Lindor K (2002). Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis. J Gastroenterol Hepatol 17:196-202
17. Nozaki I, Lunz JG 3rd, Specht S, Park JI, Giraud AS, Murase N, Demetris AJ (2004) Regulation and function of trefoil factor family 3 expression in the biliary tree. Am J Pathol 165:1907-1920
18. Portmann B, Nakanuma Y (2001) Diseases of the bile ducts. In: MacSween R, Burt A, Portmann BC, Ishak K, Scheuer P, Anthony P (eds) Pathology of the liver. Churchill Livingstone, London, pp 435-506
19. Sasaki M, Tsuneyama K, Nakanuma Y (2003) Aberrant expression of trefoil factor family 1 in biliary epithelium in hepatolithiasis and cholangiocarcinoma. Lab Invest 83:1403-1413
20. Sasaki M, Tsuneyama K, Saito T, Kataoka H, Mollenhauer J, Poustka A, Nakanuma Y (2004) Site-characteristic expression and induction of trefoil factor family 1, 2 and 3 and malignant brain tumor-1 in normal and diseased intrahepatic bile ducts relates to biliary pathophysiology. Liver Int 24:29-37
21. Sasaki M, Ikeda H, Haga H, Manabe T, Nakanuma Y (2005) Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss. J Pathol 205:451-459
22. Scheuer P (1994) Liver biopsy interpretation, 5th edn. Saunders, London
23. Sherlock S, Dooley J (1993) Primary biliary cirrhosis. In: Diseases of the liver and biliary system. Blackwell, London, pp 236
24. Shimoda S, Van de Water J, Ansari A, Nakamura M, Ishibashi H, Coppel RL, Lake J, Keeffe EB, Roche TE, Gershwin ME (1998) Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 102:1831-1840
25. Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T (1995) Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology 21:106-112
26. Shiota G, Rhoads DB, Wang TC, Nakamura T, Schmidt EV (1992) Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci USA 89:373-377
27. Strain AJ, Wallace L, Joplin R, Daikuhara Y, Ishii T, Kelly DA, Neuberger JM (1995) Characterization of biliary epithelial cells isolated from needle biopsies of human liver in the presence of hepatocyte growth factor. Am J Pathol 146:537-545
28. Tanaka H, Nagaike K, Takeda N, Itoh H, Kohama K, Fukushima T, Miyata S, Uchiyama S, Uchinokura S, Shimomura T, Miyazawa K, Kitamura N, Yamada G, Kataoka H (2005) Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta. Mol Cell Biol 25:5687-5698
29. Taupin D, Podolsky DK (2003) Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 4:721-732
30. Tsuneyama K, Harada K, Kono N, Sasaki M, Saito T, Gershwin ME, Ikemoto M, Arai H, Nakanuma Y (2002) Damaged interlobular bile ducts in primary biliary cirrhosis show reduced expression of glutathione-S-transferase-pi and aberrant expression of 4-hydroxynonenal. J Hepatol 37:176-183
31. West MD, Shay JW, Wright WE, Linskens MH (1996) Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescence. Exp Gerontol 31:175-193
32. Yokomuro S, Tsuji H, Lunz JG 3rd, Sakamoto T, Ezure T, Murase N, Demetris AJ (2000) Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells. Hepatology 32:26-35
33. Zen Y, Harada K, Sasaki M, Tsuneyama K, Katayanagi K, Yamamoto Y, Nakanuma Y (2002) Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasis. Am J Pathol 161:1475-1484